Metformin treatment of the C9orf72 ALS/FTD mouse: Almost too good for words. | Proc Natl Acad Sci U S A;117(33): 19627-19628, 2020 08 18. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Metformin treatment of the C9orf72 ALS/FTD mouse: Almost too good for words.

Rosbash, Michael.

Rosbash M; Howard Hughes Medical Institute, Brandeis University, Waltham, MA 02453; rosbash@brandeis.edu.

Proc Natl Acad Sci U S A ; 117(33): 19627-19628, 2020 08 18.

Article in English | MEDLINE | ID: covidwho-900114

Subject(s)

Amyotrophic Lateral Sclerosis/genetics; Frontotemporal Dementia/genetics; Metformin; Animals; C9orf72 Protein; DNA Repeat Expansion; Mice

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Frontotemporal Dementia / Amyotrophic Lateral Sclerosis / Metformin Limits: Animals Language: English Journal: Proc Natl Acad Sci U S A Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Frontotemporal Dementia / Amyotrophic Lateral Sclerosis / Metformin Limits: Animals Language: English Journal: Proc Natl Acad Sci U S A Year: 2020 Document Type: Article